Cargando…
Sharing Unexpected Biomarker Results with Study Participants
BACKGROUND: The Breast Cancer and the Environment Research Centers (BCERCs) include collaborators from basic sciences, epidemiology, and the community, conducting studies to investigate whether environmental exposures are associated with the timing of puberty. A pilot study of a subset of the study...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
National Institute of Environmental Health Sciences
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018486/ https://www.ncbi.nlm.nih.gov/pubmed/20876037 http://dx.doi.org/10.1289/ehp.1001988 |
_version_ | 1782196079235694592 |
---|---|
author | Hernick, Ann D. Brown, M. Kathryn Pinney, Susan M. Biro, Frank M. Ball, Kathleen M. Bornschein, Robert L. |
author_facet | Hernick, Ann D. Brown, M. Kathryn Pinney, Susan M. Biro, Frank M. Ball, Kathleen M. Bornschein, Robert L. |
author_sort | Hernick, Ann D. |
collection | PubMed |
description | BACKGROUND: The Breast Cancer and the Environment Research Centers (BCERCs) include collaborators from basic sciences, epidemiology, and the community, conducting studies to investigate whether environmental exposures are associated with the timing of puberty. A pilot study of a subset of the study participants assessed the feasibility of measuring selected biomarkers of exposure in blood and urine in girls 6–8 years of age. In the Greater Cincinnati study population, we found an elevated serum concentration of perfluorooctanoate (PFOA) among > 90% of young girls living in a small community. OBJECTIVES: The research team deliberated whether and how to report the PFOA findings to our study families. We will address the issues considered in our decision, as well as the formats we used to present the findings. METHODS: The results were verified as we searched for potential sources of the elevated PFOA levels. As a research team, we grappled with issues regarding the reporting of unexpected results, derived from unknown sources and with unknown clinical significance. Ultimately, we did decide to present these findings to the study families through a well-developed communication plan. DISCUSSION: Research team members came from a variety of experiences and backgrounds, which led to different interpretations about the clinical, ethical, and public health issues surrounding these findings. The ethical debates centered around the precautionary principle, the right to know, and do no harm. CONCLUSIONS: Given advances in environmental biomarker technologies and greater use of the transdisciplinary research model, a communication plan must be developed for those involved as study participants. |
format | Text |
id | pubmed-3018486 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | National Institute of Environmental Health Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-30184862011-02-10 Sharing Unexpected Biomarker Results with Study Participants Hernick, Ann D. Brown, M. Kathryn Pinney, Susan M. Biro, Frank M. Ball, Kathleen M. Bornschein, Robert L. Environ Health Perspect Commentary BACKGROUND: The Breast Cancer and the Environment Research Centers (BCERCs) include collaborators from basic sciences, epidemiology, and the community, conducting studies to investigate whether environmental exposures are associated with the timing of puberty. A pilot study of a subset of the study participants assessed the feasibility of measuring selected biomarkers of exposure in blood and urine in girls 6–8 years of age. In the Greater Cincinnati study population, we found an elevated serum concentration of perfluorooctanoate (PFOA) among > 90% of young girls living in a small community. OBJECTIVES: The research team deliberated whether and how to report the PFOA findings to our study families. We will address the issues considered in our decision, as well as the formats we used to present the findings. METHODS: The results were verified as we searched for potential sources of the elevated PFOA levels. As a research team, we grappled with issues regarding the reporting of unexpected results, derived from unknown sources and with unknown clinical significance. Ultimately, we did decide to present these findings to the study families through a well-developed communication plan. DISCUSSION: Research team members came from a variety of experiences and backgrounds, which led to different interpretations about the clinical, ethical, and public health issues surrounding these findings. The ethical debates centered around the precautionary principle, the right to know, and do no harm. CONCLUSIONS: Given advances in environmental biomarker technologies and greater use of the transdisciplinary research model, a communication plan must be developed for those involved as study participants. National Institute of Environmental Health Sciences 2011-01 2010-09-29 /pmc/articles/PMC3018486/ /pubmed/20876037 http://dx.doi.org/10.1289/ehp.1001988 Text en http://creativecommons.org/publicdomain/mark/1.0/ Publication of EHP lies in the public domain and is therefore without copyright. All text from EHP may be reprinted freely. Use of materials published in EHP should be acknowledged (for example, ?Reproduced with permission from Environmental Health Perspectives?); pertinent reference information should be provided for the article from which the material was reproduced. Articles from EHP, especially the News section, may contain photographs or illustrations copyrighted by other commercial organizations or individuals that may not be used without obtaining prior approval from the holder of the copyright. |
spellingShingle | Commentary Hernick, Ann D. Brown, M. Kathryn Pinney, Susan M. Biro, Frank M. Ball, Kathleen M. Bornschein, Robert L. Sharing Unexpected Biomarker Results with Study Participants |
title | Sharing Unexpected Biomarker Results with Study Participants |
title_full | Sharing Unexpected Biomarker Results with Study Participants |
title_fullStr | Sharing Unexpected Biomarker Results with Study Participants |
title_full_unstemmed | Sharing Unexpected Biomarker Results with Study Participants |
title_short | Sharing Unexpected Biomarker Results with Study Participants |
title_sort | sharing unexpected biomarker results with study participants |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018486/ https://www.ncbi.nlm.nih.gov/pubmed/20876037 http://dx.doi.org/10.1289/ehp.1001988 |
work_keys_str_mv | AT hernickannd sharingunexpectedbiomarkerresultswithstudyparticipants AT brownmkathryn sharingunexpectedbiomarkerresultswithstudyparticipants AT pinneysusanm sharingunexpectedbiomarkerresultswithstudyparticipants AT birofrankm sharingunexpectedbiomarkerresultswithstudyparticipants AT ballkathleenm sharingunexpectedbiomarkerresultswithstudyparticipants AT bornscheinrobertl sharingunexpectedbiomarkerresultswithstudyparticipants |